Rimonabant
AUDITOR
Sanofi · Phase 3 · Terminated · Enrollment 661
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Rimonabant | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- Rimonabant: endpoint not reported
- Placebo: endpoint not reported